How to transfer my Ozempic prescription to California

If you’ve been considering weight loss medications like Wegovy, Ozempic, or Mounjaro, you might be wondering: Can I get these medications through telehealth? The short answer is yes—and in most cases, it’s perfectly legal and safe. But the details vary depending on where you live.

As telehealth continues to reshape healthcare access across the United States, weight management has become one of the most popular—and sometimes confusing—areas for virtual care. With GLP-1 medications showing remarkable results for weight loss, more people are turning to online providers for prescriptions. But navigating the patchwork of federal and state regulations can feel overwhelming.

This guide will walk you through everything you need to know about getting weight loss medication via telehealth in 2025, including state-specific requirements, provider qualifications, and what to expect during your virtual visit.

Understanding the Federal Framework for Telehealth Prescribing

The Good News: GLP-1 Medications Aren’t Restricted Federally

Here’s the most important thing to understand: medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. This means the Ryan Haight Act—federal law requiring an in-person exam before prescribing controlled drugs via telehealth—doesn’t apply to these weight loss medications.

Under federal law, licensed healthcare providers can prescribe non-controlled medications like GLP-1 agonists through telehealth consultations without any mandatory in-person visit. This has been the case before, during, and after the COVID-19 pandemic.

What About the DEA Telehealth Extensions?

You may have heard news about the Drug Enforcement Administration (DEA) extending telehealth flexibilities through December 31, 2025. While this is important for medications like Adderall or anxiety medications (which are controlled substances), it doesn’t affect GLP-1 weight loss drugs.

The DEA’s extensions allow providers to prescribe controlled substances via telehealth without an initial in-person exam—a temporary flexibility that began during the pandemic. For non-controlled medications used in weight management, telehealth prescribing has always been federally permissible, assuming providers meet standard medical practice requirements.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Rules: What You Need to Know

While federal law gives the green light for telehealth prescribing of weight loss medications, individual states can impose additional requirements. Some states require an initial in-person exam, regular follow-ups, or specific documentation before prescribing these medications.

States with the Fewest Restrictions

California, Connecticut, Illinois, New York, Pennsylvania, and Washington have some of the most telehealth-friendly policies. In these states:

• No mandatory in-person visit is required before or during treatment
• Providers can establish a patient-provider relationship entirely through secure video consultations
• Follow-up visits can be conducted virtually
• Nurse practitioners often have independent prescribing authority

For example, if you’re a California resident, your entire weight loss journey—from initial consultation to ongoing monitoring—can happen through telehealth appointments. Washington State, a pioneer in telemedicine, similarly embraces virtual care without imposing extra barriers for obesity treatment.

States Requiring an Initial In-Person Exam

Several states take a more cautious approach, requiring at least one in-person evaluation:

Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Utah, and Virginia all mandate some form of in-person examination before or shortly after starting telehealth-based weight loss treatment.

What does this mean in practice?

If you live in Texas, for instance, you’ll typically need to visit a healthcare facility for your first appointment. Your provider will conduct a physical exam, review your medical history, and possibly order lab work. Once this baseline is established, subsequent appointments can often occur via telehealth—though some states require periodic in-person check-ins.

Georgia’s approach is worth noting: the state recently expanded prescribing authority for nurse practitioners and physician assistants (allowing them to prescribe Schedule II medications with physician oversight as of July 2024), but still maintains its initial in-person requirement for weight management medications.

Virginia takes patient safety seriously with comprehensive initial requirements: providers must perform a physical examination, order relevant lab work, create a personalized diet and exercise plan, and schedule a follow-up visit within 30 days of starting medication. These requirements apply whether you’re seeing your provider in person or via telehealth.

States with Special Monitoring Requirements

Florida has unique rules that go beyond just the initial visit. To prescribe weight loss medications in Florida:

• Patients must have a BMI of 30 or higher (or 27+ with weight-related health conditions)
• Follow-up appointments are required at least every three months
• Providers must document ongoing lifestyle modifications alongside medication therapy

New Jersey requires one of the most thorough evaluations in the country. Before prescribing any weight loss medication, New Jersey providers must:

• Conduct a comprehensive medical history review
• Perform a complete physical examination
• Order and review laboratory tests
• Complete a psychological screening
• Develop an individualized treatment plan that includes dietary counseling and exercise recommendations
• Obtain detailed informed consent that covers potential risks and side effects

Connecticut mandates that obesity treatment include behavioral counseling and a documented diet and exercise plan—not just the medication prescription.

Who Can Prescribe Weight Loss Medications via Telehealth?

Medical Doctors and Doctors of Osteopathy

In all 50 states, licensed physicians (MDs and DOs) can prescribe GLP-1 medications through telehealth, provided they’re licensed in the state where the patient is physically located during the consultation. Most telehealth platforms employ or contract with physicians licensed in multiple states to serve patients nationwide.

Nurse Practitioners (NPs)

Nurse practitioner prescribing authority varies significantly by state, falling into three categories:

Full Practice Authority (34 states plus DC): In states like Arizona, Colorado, Maryland, Nevada, New York, and Washington, NPs with appropriate experience can evaluate patients, diagnose conditions, and prescribe medications independently—including weight loss drugs. Many established telehealth platforms leverage NP providers in these states to increase access.

Reduced Practice Authority (13 states): States like Georgia, Ohio, Tennessee, and Virginia allow NPs to prescribe after fulfilling collaboration or supervision requirements with a physician. The level of physician involvement varies—some states require a formal written agreement, while others mandate periodic chart reviews.

Restricted Practice (3 states): A handful of states maintain tight restrictions on NP prescribing. However, even in these states, NPs can typically still prescribe GLP-1 medications when working under appropriate physician oversight.

Recent changes to watch: Michigan and Indiana granted full practice authority to NPs in 2024, joining the growing majority of states recognizing NP independence. Mississippi and Pennsylvania have pending legislation that could expand NP authority in 2026.

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all states, but like NPs, they work under varying degrees of physician collaboration. Most states require PAs to have a supervising physician and a written practice agreement that outlines their scope of practice.

Texas maintains particularly strict oversight: PAs must have a formal physician delegation agreement, and while they can prescribe most medications, certain controlled substances remain off-limits even with delegation (though this doesn’t affect GLP-1 drugs).

The Telehealth Visit: What to Expect

Your Initial Consultation

When you schedule a telehealth appointment for weight loss medication, expect a thorough evaluation—not a rubber-stamp prescription. Reputable providers follow the same standard of care as in-person visits.

Your virtual visit will typically include:

Medical History Review: Your provider will ask about your weight history, previous weight loss attempts, current medications, allergies, and any existing health conditions. Be prepared to discuss your diet, exercise habits, and weight loss goals.

Health Assessment: You’ll need to provide current measurements (height, weight, blood pressure if available). Many providers ask patients to step on a scale during the video call or submit photos of their scale reading. Some may request recent lab results or order new bloodwork.

Screening for Contraindications: Your provider will carefully screen for conditions that would make GLP-1 medications unsafe, including:

• Personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current or planned pregnancy
• History of pancreatitis
• Active gallbladder disease
• Severe gastroparesis or gastrointestinal disorders

Informed Consent: Your provider should explain how these medications work, potential side effects (commonly nausea, vomiting, diarrhea, constipation), and the importance of combining medication with lifestyle changes. You’ll discuss realistic expectations—these aren’t ‘quick fix’ pills, but tools to support sustained weight loss over several months.

Treatment Planning: A comprehensive plan includes not just medication, but also nutrition guidance, physical activity recommendations, and a follow-up schedule.

Ongoing Monitoring

Weight loss medication isn’t prescribed and forgotten. Proper telehealth care includes regular check-ins:

• First follow-up: Usually scheduled 2-4 weeks after starting medication to assess tolerance and adjust dosage
• Routine monitoring: Most providers schedule monthly or bi-monthly video visits during the first few months
• Long-term care: Once stable, appointments may spread to every 2-3 months (though states like Florida legally require at least quarterly visits)

During follow-ups, your provider will review your weight progress, discuss any side effects, adjust your dose as needed, and assess whether the medication remains appropriate for you.

Understanding the Medications: Wegovy, Ozempic, and Mounjaro

Wegovy (Semaglutide 2.4mg)

FDA Approval: Approved specifically for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition.

How it works: Weekly injection that mimics a natural hormone (GLP-1) to reduce appetite and slow stomach emptying, helping you feel full longer.

Typical results: Clinical trials showed average weight loss of 15-20% of body weight over 68 weeks when combined with lifestyle interventions.

Telehealth considerations: Fully prescribable via telehealth in compliant states. Requires patient education on self-injection technique, proper storage (refrigeration), and dose escalation schedule.

Ozempic (Semaglutide 0.5–1mg)

FDA Approval: Approved for Type 2 diabetes management, not weight loss—but widely prescribed off-label for obesity.

Same ingredient, different indication: Ozempic contains the same active ingredient as Wegovy but at different doses. It’s commonly used off-label for weight loss, particularly when Wegovy is unavailable or insurance doesn’t cover it.

Telehealth considerations: Providers can prescribe Ozempic off-label for weight loss, but must document medical rationale and obtain informed consent about off-label use. Patients should understand they’re using a diabetes medication for a different purpose.

Important note: Never combine Ozempic with Wegovy or other semaglutide products—they contain the same medication.

Mounjaro (Tirzepatide)

FDA Approval: Approved for Type 2 diabetes. Its weight loss formulation, Zepbound, was approved by the FDA in late 2023 specifically for obesity.

How it works: Dual-action medication that activates both GLP-1 and GIP receptors, potentially leading to greater weight loss than semaglutide alone.

Typical results: Studies show average weight loss of 20-25% of body weight—among the highest for any weight loss medication.

Telehealth considerations: Can be prescribed via telehealth for weight loss (increasingly under the Zepbound brand for obesity indication). Requires similar patient education and monitoring as semaglutide products.

What About Compounded Versions?

Critical update: In May 2025, the FDA banned most compounding of semaglutide for weight loss after declaring the drug shortage resolved. This means legitimate telehealth providers can only prescribe FDA-approved, brand-name versions (Wegovy, Ozempic, Zepbound, Mounjaro) filled by licensed pharmacies—not custom-compounded alternatives.

Some telehealth companies that previously offered cheaper compounded options had to discontinue those services. While this increases cost for patients, it ensures medication safety, proper dosing, and FDA oversight.

Am I a Good Candidate for Telehealth Weight Loss Treatment?

Clinical Eligibility

To qualify for GLP-1 medications through telehealth, you generally need:

BMI Requirements:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with at least one weight-related health condition (such as high blood pressure, Type 2 diabetes, high cholesterol, or sleep apnea)

Previous Weight Loss Attempts: Most providers want to see that you’ve tried lifestyle modifications (diet and exercise changes) without sufficient success—though this isn’t always a strict requirement if your BMI is significantly elevated.

Commitment to Lifestyle Changes: These medications work best when combined with healthier eating and increased physical activity. Providers will assess your readiness to make sustainable changes.

No Contraindications: You must not have any medical conditions that would make these medications dangerous (see screening section above).

Who Might NOT Be a Good Candidate

Telehealth weight loss treatment may not be appropriate if you:

• Need to lose only 10-15 pounds for cosmetic reasons (these medications are for clinical obesity, not vanity weight loss)
• Have a history of eating disorders that could be worsened by appetite suppression
• Are pregnant, breastfeeding, or planning pregnancy in the near future
• Have specific medical contraindications your provider identifies
• Are looking for a ‘quick fix’ without commitment to long-term lifestyle changes

Red Flags: How to Spot Illegitimate Telehealth Services

Unfortunately, the popularity of weight loss medications has attracted some less scrupulous operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Evaluation

Red flag: Any service that promises you’ll get a prescription before you’ve even had a consultation, or that advertises ‘no doctor visit required.’

What’s appropriate: Legitimate providers conduct a thorough evaluation and may decline to prescribe if you don’t meet medical criteria or have contraindications.

Selling Compounded or ‘Generic’ Versions

Red flag: Since May 2025, FDA-compliant providers should only prescribe brand-name, FDA-approved medications (not compounded alternatives marketed as ‘generic semaglutide’).

What’s appropriate: Prescriptions filled at licensed U.S. pharmacies using FDA-approved medications (Wegovy, Ozempic, Mounjaro, Zepbound).

No Follow-Up or Monitoring

Red flag: Services that send medication without scheduling check-ins, or that never require you to report back on your progress or side effects.

What’s appropriate: Regular follow-up appointments (at minimum monthly initially, then every 2-3 months) to monitor weight loss, side effects, and overall health.

Unclear Provider Credentials

Red flag: Not telling you who your prescriber is, what state they’re licensed in, or making it difficult to verify their credentials.

What’s appropriate: Clear disclosure of provider names, licenses, and credentials. You should be able to look up your provider in your state’s medical or nursing board database.

Pressure Tactics or Excessive Marketing

Red flag: High-pressure sales tactics, exaggerated weight loss promises (‘Lose 50 pounds in 8 weeks!’), or celebrity endorsements that make these medications sound like miracle cures.

What’s appropriate: Realistic discussions of expected outcomes (typically 1-2 pounds per week), honest conversations about side effects, and emphasis on medication as one tool among many.

Lack of Transparent Pricing

Red flag: Hidden fees, unclear billing practices, or surprise charges after your initial consultation.

What’s appropriate: Upfront, transparent pricing for consultations and any platform fees. (Note: medication costs at the pharmacy are separate and depend on your insurance coverage.)

How Klarity Health Approaches Telehealth Weight Management

At Klarity Health, we believe weight loss treatment should be accessible, affordable, and safe. Our approach prioritizes:

Comprehensive Evaluations: Every patient receives a thorough video consultation with a licensed provider (physician or nurse practitioner) who takes time to understand your medical history, weight loss goals, and lifestyle.

State Compliance: We ensure all providers are properly licensed in your state and follow state-specific requirements for prescribing weight loss medications—including arranging in-person visits when your state requires them.

Transparent Pricing: You’ll know the cost of your consultation upfront. We accept both insurance and cash pay, giving you flexibility in how you access care.

Provider Availability: Our network of providers means you can usually schedule an appointment within days, not weeks—because we know that when you’re ready to take action on your health, timing matters.

Ongoing Support: Weight loss isn’t a one-and-done appointment. We build follow-up into your care plan and make it easy to reach your provider with questions between visits.

Evidence-Based Care: We prescribe only FDA-approved medications and follow clinical guidelines for obesity treatment, including combining medication with lifestyle counseling.

Whether you’re in a state with straightforward telehealth rules or one requiring additional steps, Klarity can help you navigate the process and get the care you need.

Insurance Coverage and Cost Considerations

Does Insurance Cover Weight Loss Medications via Telehealth?

The consultation: Most insurance plans cover telehealth visits the same as in-person visits. If your plan covers weight management consultations, the virtual visit should be covered (subject to your copay or deductible).

The medication: This is where it gets tricky. Many insurance plans historically excluded weight loss medications from coverage, considering them ‘cosmetic’ or ‘lifestyle’ drugs. However, coverage is improving:

• Some plans now cover Wegovy or Zepbound for obesity treatment, especially if you have weight-related health conditions
• Medicare Part D plans can cover these medications for diabetes management (Ozempic, Mounjaro) but not purely for weight loss under current rules
• More employers are adding obesity medication coverage as they recognize the long-term health cost savings

Prior authorization: Even when covered, insurance companies often require prior authorization—your provider submits clinical documentation showing you meet medical criteria, and the insurer reviews before approving coverage.

Cash Pay Options

If your insurance doesn’t cover these medications (or your deductible is high), cash pay is an option:

Manufacturer savings programs: Both Novo Nordisk (maker of Wegovy/Ozempic) and Eli Lilly (maker of Mounjaro/Zepbound) offer savings cards that can significantly reduce out-of-pocket costs for eligible patients—sometimes to as low as $25 per month for a limited time.

Telehealth subscription models: Some telehealth companies offer all-inclusive monthly packages that bundle the provider visit, medication, and support services—though always verify what’s included and whether it’s actually a better deal than using your insurance.

Cost comparison: Without insurance or savings programs, these medications can cost $900-$1,400 per month. With manufacturer assistance and insurance, many patients pay $25-$100 monthly.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Regulatory Trends

The telehealth landscape continues to evolve in patient-friendly directions:

Federal level: While the DEA’s controlled substance telehealth flexibilities remain temporary (extended through December 2025), proposed legislation like the TREATS Act could make some flexibilities permanent. For GLP-1 medications (which aren’t controlled), federal support for telehealth continues to grow.

State level: More states are loosening restrictions on telehealth prescribing and expanding nurse practitioner scope of practice. The trend is toward greater access while maintaining appropriate safety standards.

Interstate practice: Physician and NP interstate compacts now allow providers to practice in multiple states more easily, expanding telehealth access for patients in underserved areas.

New Medications on the Horizon

The weight loss medication landscape is rapidly expanding. Several new GLP-1 and dual-action medications are in clinical trials or awaiting FDA approval, which will give patients and providers more options. Telehealth will play a crucial role in ensuring these new treatments reach patients who can benefit from them.

Increasing Recognition of Obesity as a Chronic Disease

Medical societies, insurers, and policymakers increasingly recognize obesity as a chronic medical condition requiring ongoing treatment—not a personal failing or lifestyle choice. This shift is driving:

• Expanded insurance coverage for obesity medications
• More relaxed prescribing rules via telehealth
• Integration of obesity treatment into primary care (including virtual primary care)
• Reduced stigma around seeking medical help for weight management

Taking the Next Step: Getting Started with Telehealth Weight Loss Treatment

If you’re considering weight loss medication and wondering whether telehealth is right for you, here’s how to move forward:

1. Check Your State’s Requirements

Review the state-specific table in this article to understand whether your state requires an initial in-person visit or has special follow-up rules. This will help you choose a provider who can meet those requirements.

2. Verify Provider Credentials

Choose a telehealth platform that:

• Clearly identifies licensed providers
• Follows state and federal prescribing laws
• Offers transparent pricing
• Provides ongoing support, not just one-time prescriptions

3. Gather Your Medical Information

Before your appointment, collect:

• Current height and weight
• List of current medications and supplements
• Medical history (especially thyroid conditions, diabetes, gastrointestinal issues)
• Insurance information (if using insurance)
• Recent lab results (if available)

4. Prepare Your Questions

Come to your consultation with questions about:

• Expected timeline for results
• Potential side effects and how to manage them
• Cost and insurance coverage
• What happens if the medication doesn’t work for you
• Long-term treatment plans

5. Schedule Your Consultation

Ready to take action? Klarity Health makes it easy to schedule a weight loss consultation with a licensed provider in your state. Our team will guide you through your options, answer your questions, and help you understand whether GLP-1 medications are right for you.

Schedule your confidential consultation today and take the first step toward sustainable weight loss with professional support every step of the way.

Frequently Asked Questions

Is it safe to get weight loss medication through telehealth?

Yes, when prescribed by a licensed provider following appropriate medical protocols. Telehealth platforms must follow the same standards of care as in-person clinics—including thorough evaluations, contraindication screening, and ongoing monitoring. The key is choosing a reputable provider who conducts comprehensive assessments and doesn’t just hand out prescriptions.

How long does a telehealth weight loss consultation take?

Initial consultations typically last 30-45 minutes, allowing time for a thorough medical history review, discussion of your goals, education about medications, and treatment planning. Follow-up appointments are usually shorter, around 15-20 minutes.

Can I use my regular insurance for telehealth weight loss treatment?

Most insurance plans cover telehealth consultations the same as in-person visits. However, whether your insurance covers the actual weight loss medication varies significantly by plan. Check with your insurance provider about coverage for obesity medications, and ask about prior authorization requirements.

What if I don’t qualify for medication?

Not everyone is a candidate for GLP-1 medications—and that’s okay. A good provider will help you explore other evidence-based weight loss strategies, whether that’s different medications, referral to a nutritionist, or structured lifestyle programs. The goal is finding what works safely for you.

Do I need to stay with the same telehealth provider throughout treatment?

Consistency is beneficial for optimal care. Your provider gets to know your response to medication and can adjust treatment accordingly. However, you can switch providers if needed—just ensure proper continuity of care with medical records transfer.

What happens if I move to a different state during treatment?

Your provider must be licensed in the state where you’re physically located at the time of the consultation. If you move, you’ll need to transfer care to a provider licensed in your new state. Many national telehealth platforms have providers in multiple states and can facilitate this transition.

About Klarity Health

Klarity Health provides accessible, affordable telehealth services for mental health and weight management. Our network of licensed providers offers evidence-based treatment with transparent pricing, accepting both insurance and cash pay. With appointments available within days and providers licensed across multiple states, Klarity makes it easier to get the care you need, when you need it.

Research Currency Statement

Verified as of: December 17, 2025

DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.

States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of December 2025)

Note: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025)—an additional extension or new rule is expected. State laws continue to evolve; monitor for changes in 2026, particularly regarding NP practice authority and telehealth standards.

Citations

1. DEA and HHS Announcement (November 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ – Official government release confirming extension of COVID-era telehealth prescribing rules for controlled substances through December 31, 2025. www.dea.gov

2. Axios News (November 2024) – ‘COVID-era telehealth prescribing extended’ – News analysis confirming DEA’s one-year extension and implications for telemedicine prescribing practices. www.axios.com

3. McDermott Will & Emery Legal Analysis (November 2024) – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ – Expert legal analysis of DEA regulations and telemedicine framework, including discussion of the Ryan Haight Act’s application to controlled versus non-controlled substances. www.mwe.com

4. Goodwin Procter Healthcare Alert (March 2024) – ‘The Changing Regulatory & Reimbursement Landscape for Weight Loss Drugs’ – Comprehensive legal analysis of state-specific regulations for weight loss medications in Florida, New Jersey, and Virginia, including prescribing requirements and standard-of-care considerations. www.goodwinlaw.com

5. Reuters Healthcare News (May 2025) – ‘Hims to cut 4% of workforce amid ban on weight-loss drug copies’ – Reporting on FDA’s May 2025 ban on compounded semaglutide for weight loss and impact on telehealth industry practices. www.reuters.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid